Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.290
+0.030 (2.38%)
At close: Aug 22, 2025, 4:00 PM
1.290
0.00 (0.00%)
Pre-market: Aug 25, 2025, 4:04 AM EDT
Company Description
Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region.
It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products.
The company has a strategic alliance with IDT Australia Limited for the development and scale up of its gel-based products across diverse global pharmaceutical, nutraceutical and animal health markets.
Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.
Gelteq Limited
| Country | Australia |
| Founded | 2018 |
| IPO Date | Oct 29, 2024 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Nathan Givoni |
Contact Details
Address: 639-641 Glenhuntly Road Caulfield, VIC 3162 Australia | |
| Phone | 61 3 9087 3990 |
| Website | gelteq.com |
Stock Details
| Ticker Symbol | GELS |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| IPO Price | $4.00 |
| CIK Code | 0001920092 |
| ISIN Number | AU0000218109 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Nathan Jacob Givoni | Co-Founder, Chief Executive Officer and Executive Director |
| Simon Hayden Szewach | Co-Founder and Non-Executive Chairman |
| Thuy-Linh Gigler | Chief Financial Officer |
| Dr. Paul M. Wynne | Chief Scientific Officer |
| Adam Bendell | President of U.S. Operations |
| Matthew Jones | Head of Sports Performance |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 25, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Jul 1, 2025 | F-1 | Registration statement for certain foreign private issuers |
| Jun 30, 2025 | 6-K | Report of foreign issuer |
| Mar 14, 2025 | 6-K | Report of foreign issuer |
| Nov 15, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Oct 31, 2024 | NT 20-F | Notification of inability to timely file Form 20-F |
| Oct 30, 2024 | 6-K | Report of foreign issuer |
| Oct 28, 2024 | CERT | Certification by an exchange approving securities for listing |
| Oct 22, 2024 | 424B4 | Prospectus |
| Oct 17, 2024 | 8-A12B | Registration of securities |